Neurocrine Biosciences reported $6.1M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Acorda Therapeutics ACOR:US USD 11M 2.2M
Agios Pharmaceuticals AGIO:US USD 517K 82K
ALKERMES ALKS:US USD 50.62M 7.74M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amgen AMGN:US USD 1.59B 78M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Dynavax Technologies DVAX:US USD 61.33M 22.04M
Exelixis EXEL:US USD 15.3M 1.82M
Gilead Sciences GILD:US USD 1.4B 47M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Neurocrine Biosciences NBIX:US USD 6.1M 1.3M
Pfizer PFE:US USD 6.09B 2.58B
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Repligen RGEN:US USD 86.51M 254K
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
YTE INCY:US USD 49.28M 4.05M